The Natural History of Herpes Simplex Virus Infection of Mother and Newborn
1 Departments of Pediatrics, Microbiology, and Biostatistics, and the Comprehensive Cancer Center of the University of Alabama in Birmingham School of Medicine, Birmingham; National Institutes of Health, Bethesda, Maryland; and Emory University, Atlanta
The controlled evaluation of vidarabine as therapy of neonatal herpes simplex virus (HSV) infection provided an opportunity to collect data to further assess the natural history of maternal and newborn infections. Women delivering infected babies were young, nulliparous, and infrequent aborters. Nearly 50% of the gestations ended in premature labor. Maternal infection was asymptomatic in 39 of 56 (70%) of the mothers, at the time of delivery. However, risk factors included a past history of genital herpes at any time and exposure to a sexual partner with presumed HSV lesions. Associated diseases in children born to these women were common. Premature infants had an incidence of respiratory distress of 52% (14 of 27). Eight of 29 (28%) term newborns had a bacterial infection, antedating the onset of neonatal HSV infection. Virologic studies on infected newborns confirmed that skin lesions were the most frequent site for virus retrieval. Progression of disease from isolated skin lesions was common, occurring in 70% of babies whose presenting sign was skin vesicles. CSF was virus-positive from 14 babies and more frequently in those with localized CNS disease. Importantly, brain biopsy was necessary for diagnosis in four cases. Finally, neither the presence or absence of antibodies to HSV was useful in predicting either presentation or outcome of infection. These studies further emphasize the complex nature of HSV infections of the newborn and need for tertiary care.
Submitted on March 10, 1980Accepted on April 23, 1980
This article has been cited by other articles:
 |
|
 |
|
  A. C. Caviness, G. J. Demmler, J. M. Swint, and S. B. Cantor Cost-effectiveness Analysis of Herpes Simplex Virus Testing and Treatment Strategies in Febrile Neonates Arch Pediatr Adolesc Med, July 1, 2008; 162(7): 665 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Fernandez, F. K. Puttur, Y. M. Wang, W. Howden, S. I. Alexander, and C. A. Jones T Regulatory Cells Contribute to the Attenuated Primary CD8+ and CD4+ T Cell Responses to Herpes Simplex Virus Type 2 in Neonatal Mice J. Immunol., February 1, 2008; 180(3): 1556 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Stanberry Neonatal Herpes in Premature Infants: A Special Problem Pediatrics, December 1, 2006; 118(6): 2543 - 2544. [Full Text] [PDF]
|
|
|
|
|
|
D. P. O'Riordan, W. C. Golden, and S. W. Aucott Herpes Simplex Virus Infections in Preterm Infants Pediatrics, December 1, 2006; 118(6): e1612 - e1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Frenkel Challenges in the Diagnosis and Management of Neonatal Herpes Simplex Virus Encephalitis Pediatrics, March 1, 2005; 115(3): 795 - 797. [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Kimberlin Neonatal Herpes Simplex Infection Clin. Microbiol. Rev., January 1, 2004; 17(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Kimura, M Futamura, Y Ito, Y Ando, S Hara, H Sobajima, Y Nishiyama, and T Morishima Relapse of neonatal herpes simplex virus infection Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F483 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Brown, A. Wald, R. A. Morrow, S. Selke, J. Zeh, and L. Corey Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to Infant JAMA, January 8, 2003; 289(2): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Kimberlin, C.-Y. Lin, R. F. Jacobs, D. A. Powell, L. M. Frenkel, W. C. Gruber, M. Rathore, J. S. Bradley, P. S. Diaz, M. Kumar, et al. Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era Pediatrics, August 1, 2001; 108(2): 223 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Kimberlin, C.-Y. Lin, R. F. Jacobs, D. A. Powell, L. Corey, W. C. Gruber, M. Rathore, J. S. Bradley, P. S. Diaz, M. Kumar, et al. Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections Pediatrics, August 1, 2001; 108(2): 230 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. DAMMANN and A. LEVITON Is some white matter damage in preterm neonates induced by a human pestivirus? Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 230F - 231. [Full Text]
|
|
|
|
 |
|
 R. Ashley, L Wu, J. Pickering, M. Tu, and L Schnorenberg Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies [In Process Citation] J. Clin. Microbiol., January 1, 1998; 36(1): 294 - 295. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. J. Vitale, L. Saiman, and J. Haddad Jr Herpes Laryngitis and Tracheitis Causing Respiratory Distress in a Neonate Arch Otolaryngol Head Neck Surg, February 1, 1993; 119(2): 239 - 240. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Zabinski, K. Vance-Bryan, and J. C. Rotschafer The Management of Central Nervous System Infections Journal of Pharmacy Practice, January 1, 1991; 4(3): 170 - 191. [PDF]
|
|
|
|
 |
|
 N. J. Binkin and J. P. Koplan The High Cost and Low Efficacy of Weekly Viral Cultures for Pregnant Women with Recurrent Genital Herpes: A Reappraisal Med Decis Making, December 1, 1989; 9(4): 225 - 230. [Abstract] [PDF]
|
|
